A number of investigators have provided experimental evidence for synergistic effects in mixed infections with Escherichia coli and Bacteroides fragilis. In vitro studies have suggested that competition for serum opsonins and diminished subsequent phagocytosis by polymorphonuclear leukocytes might explain these effects. In the present study we evaluated the effect of B. fragilis on macrophage phagocytosis. It was shown that peritoneal macrophages from mice injected intravenously 6 to 12 h earlier with 108 CFU of encapsulated B. fragilis were markedly suppressed in their phagocytic ability. Injections of laboratory-passaged, lessencapsulated B. fragilis, other bacteria, or latex particles were either not suppressive of macrophage phagocytosis or less effective. When peritoneal macrophages were treated in vitro for 24 h with the same challenge organisms prior to assessing their phagocytic capacity, encapsulated B. fragilis also proved significantly more suppressive than challenges with other organisms or latex particles. We conclude that suppression of macrophage phagocytosis by B. fragilis seems to be an important mechanism contributing to synergistic effects described for mixed aerobic and anaerobic infections.
A considerable number of clinical infections involve more than one etiologic agent. Infections after surgery often include both aerobic and anaerobic bacteria, and quite commonly, Escherichia coli and Bacteroides fragilis are found in association (6) . Lately, considerable interest has focused on the pathogenic contribution of the anaerobic organisms in these mixed infections. Using a rat peritonitis model, Onderdonk et al. (14) demonstrated synergism of Bacteroides species and E. coli in abscess formation. However, encapsulated B. fragilis by itself or its isolated capsular material subsequently was shown to induce the same frequency of abscess formation (15) . Investigating surgical incisions in guinea pigs, Kelly (13) reported on synergistic effects of B. fragilis and E. coli resulting in augmented bacterial growth and pus formation. Rodloff and Hahn (19) evaluated the effect of combined intravenous injections of E. coli and B. fragilis in murine hosts. It was found that encapsulated B. fragilis enhanced animal lethality due to an appropriate challenge with either E. coli or, in a timedependent manner, E. coli lipopolysaccharide (18) . The mechanisms responsible for these synergistic infections are still unclear. Kasper et al. (12, 15, 16, 21, 22) showed that the polysaccharide capsule of B. fragilis is an important virulence factor; however, its possible role in mixed infections is still undetermined. A number of reports have provided evidence that the addition of anaerobic bacteria to leukocyte cultures suppresses phagocytosis and killing of facultatively aerobic bacteria by polymorphonuclear leukocytes (9-11), but similar effects could not be demonstrated in vivo (5, 17) . Little is known about the effects anaerobes might have on macrophages, although these cells play an eminent role in early events of host defenses. Moreover, previous studies comparing the effect of either B. fragilis or thioglycolate * Corresponding author.
injections in experimental mixed infections showed that both could enhance animal susceptibility to subsequent challenges with E. coli (20) . Since thioglycolate is known to alter macrophage functions (1, 23) , these findings prompted us to investigate the role of B. fragilis in this respect. Hence, the present study was designed to evaluate the effects of B. fragilis on macrophage phagocytosis in vivo and in vitro.
MATERIALS AND METHODS
Mice. Specific-pathogen-free, female (C57BL/6 x DBA/2)F1 mice (Jackson Laboratory, Bar Harbor, Maine), approximately 8 to 10 weeks of age and weighing about 22 g each, were used throughout the study. The mice were kept in groups of three to six in pathogen-free conditions and fed commercial mouse pellets and water ad libitum.
Microorganisms and media. As in previous studies (19) , B. fragilis ATCC 25285 was used either heavily encapsulated after at least 10 subsequent animal passages (strain BFa) or less encapsulated after repeated laboratory subculturing (strain BFl). Earlier, we have shown that these procedures result in significant differences in encapsulation as determined by electron microscopy (19 ] 3.7 g of NaHCO3, 100 ml of heat-inactivated fetal bovine serum, 100,000 U of penicillin, and 0.01 g of streptomycin) to yield a concentration of 109 bacteria per ml as determined by Petroff-Hausser and Helber chamber counts. LP suspensions were established accordingly.
Radiolabeling Experimental infections of mice. Fresh suspensions of bacteria or LP as described above were used immediately to infect experimental animals. Groups of three to six mice received intravenous injections of 0.2 ml each, equivalent to doses of 108 CFU or particles, respectively. This dose was selected since in earlier studies it was shown to be necessary and sufficient to induce synergistic effects in mixed infections (19, 20 (Fig. 1) . At (Fig. 3) . 
DISCUSSION
In experimental mixed infections with E. coli and B. fragilis, several investigators have observed pathogenic effects that could not be attributed to any one organism acting alone (3, 7, 8, 13, 14, 18, 19) . For example, higher concentrations of bacteria were seen at infected sites (13, 19) , and animals infected with both organisms displayed higher lethality than that expected from results obtained with monoinfections (3, 19) . To elucidate mechanisms possibly involved in this synergy, a number of authors have investi-120 100 + gated the influence of Bacteroides species on the host immune system. Ingham and co-workers (10) consumption in vitro that in turn decreases phagocytosis of E. coli by polymorphonuclear leukocytes. However, with intraperitoneal injections of mixed cultures in mice (17) or rats (5), other authors failed to demonstrate any apparent effect of B. fragilis on the clearance of E. coli from the peritoneal cavity of experimental animals and concluded that the above mechanisms are not operative in vivo.
The present study was conducted to evaluate the influence B. fragilis might have on nonspecific phagocytosis by macrophages that might contribute to synergistic effects in mixed aerobic and anaerobic infections. Unlike previous authors (5, 17), we used an animal model which actually exhibits synergistic effects for infections with E. coli and B. fragilis (18, 19) . In this experimental model, encapsulated B. fragilis clearly suppressed nonspecific phagocytosis by macrophages obtained from infected mice at defined times. Maximal suppression was seen 6 to 12 h p.i. (Fig. 1 (Fig. 2) . In vitro experiments showed BFa and BFl to be considerably more effective in suppressing yeast phagocytosis than E. coli, L. monocytogenes, S. pneumoniae, or LP, again suggesting that overloading of the macrophage with particulate matter cannot fully explain the suppression described here. Unlike in previous studies (5, 17) , BFa- induced inhibition of phagocytosis of other organisms cannot be attributed to mere competition for serum complement, since the test system used is opsonin independent. Thus, the actual mechanism of the suppression of phagocytosis observed here remains unclear. However, it appears that the polysaccharide capsule of B. fragilis is instrumental in causing the effects shown, since BFl was significantly less active than the animal-passaged, heavily encapsulated BFa. The suppression in independent in vivo and in vitro studies, as well as its apparent effectiveness early in the infectious process, suggests that it contributes significantly to the synergistic pathogenicity of mixed infections shown for this experimental model.
